Clinical Trial Update: Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing whether TachoSil reduces lymphoceles after extended pelvic lymph node dissection in prostate or bladder cancer; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Prostate Cancer

Drugs mentioned

• TachoSil (fibrin sealant patch)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Prostate or Bladder Cancer | Phase 4 | Status: COMPLETED